QIPT vs EHAB

For growth investors, Enhabit, Inc.

(EHAB) is the stronger pick with 2. 4% revenue growth year-over-year, versus -0. 2% for Quipt Home Medical Corp. (QIPT). Analysts rate Quipt Home Medical Corp. (QIPT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Enhabit, Inc.

(EHAB) delivered a total return of -44. 9%, compared to -45. 0% for Quipt Home Medical Corp. (QIPT). Over 10 years, the gap is even starker: QIPT returned +351. 7% versus EHAB's -44. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Quipt Home Medical Corp.

(QIPT) is the lower-risk stock at -0. 03β versus Enhabit, Inc. 's 0. 44β — meaning EHAB is approximately -1376% more volatile than QIPT relative to the S&P 500. On balance sheet safety, Enhabit, Inc. (EHAB) carries a lower debt/equity ratio of 89% versus 106% for Quipt Home Medical Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Enhabit, Inc.

(EHAB) is pulling ahead at 2. 4% versus -0. 2% for Quipt Home Medical Corp. (QIPT). On earnings-per-share growth, the picture is similar: Enhabit, Inc. grew EPS 97. 1% year-over-year, compared to -56. 3% for Quipt Home Medical Corp.. Over a 3-year CAGR, QIPT leads at 20. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Enhabit, Inc.

(EHAB) is the more profitable company, earning -0. 4% net margin versus -4. 4% for Quipt Home Medical Corp. — meaning it keeps -0. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EHAB leads at 6. 0% versus -1. 6% for QIPT. At the gross margin level — before operating expenses — QIPT leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for QIPT: 0.

0% to $3. 65.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Quipt Home Medical Corp.

(QIPT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 03), +351. 7% 10Y return). Both have compounded well over 10 years (QIPT: +351. 7%, EHAB: -44. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.